Jeffrey Jones
Chief Tech/Sci/R&D Officer at CULLINAN THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/04/2024
Profile
Jeffrey Jones is currently the Chief Medical Officer at Cullinan Oncology, Inc. He previously worked as the Vice President-Global Drug Development & Lymphoma at Bristol Myers Squibb Co. from 2017 to 2022.
Prior to that, he was an Associate Professor at The Ohio State University College of Medicine and the Chief Medical Officer at Cullinan Oncology LLC.
Dr. Jones holds an MBA from Fisher College of Business, a doctorate from the University of Michigan Medical School, and a graduate degree from The University of Texas Health Science Center at Houston.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/02/2024 | 118,691 ( 0.28% ) | 2 M $ | 30/04/2024 |
Jeffrey Jones active positions
| Companies | Position | Start |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/02/2022 |
Former positions of Jeffrey Jones
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 01/04/2020 |
| The Ohio State University College of Medicine | Corporate Officer/Principal | - |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Training of Jeffrey Jones
| University of Michigan Medical School | Doctorate Degree |
| Fisher College of Business | Masters Business Admin |
| The University of Texas Health Science Center at Houston | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 1 |
|---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
- Stock Market
- Insiders
- Jeffrey Jones